Will FDA now stop conducting GMP inspections?
Recommendation
11/12 February 2025
Heidelberg, Germany
Medicinal Products/Drugs meet Medical Devices
Register now for ECA's GMP Newsletter
The European Medicines Agency, EMA, has updated its Q&A section on the Mutual Recognition Agreement. The questions mainly refer to the start of the operating phase of the agreement on 01 November 2017.
An important question is whether from 1 November 2017 FDA will stop conducting GMP inspections in all the EU Member States. It is pointed out that "it is expected" that FDA will not perform inspections in an EU Member State when the respective competent authorities have already been recognized by FDA. Currently these are Austria, Croatia, France, Italy, Malta, Spain, Sweden and United Kingdom. That means that FDA can and will still perform inspections in the states not recognized yet.
In this context, two more questions and answers complement the information:
"The number of recognized authorities will be gradually expanded with further assessment. The MRA foresees that all EU Member States are assessed by latest 15 July 2019." And that "the EU is publishing the list of recognized authorities" which will be regularly updated.
Related GMP News
15.01.2025Securing Europe's Drug Supply: How EDSForm is Addressing Medicine Shortages
15.01.2025FDA proposes Standardized Testing for Asbestos in Talc-Containing Cosmetic Products
08.01.20252nd Version of the Union list of Critical Medicines published
18.12.2024What are the GMP Requirements for Consultants?
18.12.2024ICH published updated Q8/Q9/Q10 Questions & Answers Document
11.12.2024European Shortages Monitoring Platform (ESMP) has gone live